Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm

Atherosclerosis

Volumn 142, Issue 1, 1999, Pages 179-184

  Ohmura, Hirotoshi ^a   Watanabe, Yoshiro ^a   Hatsumi, Chie ^a   Sato, Hitoshi ^a   Daida, Hiroyuki ^a   Mokuno, Hiroshi ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Coronary artery spasm; HDL; LDL; Peroxidative modification

Indexed keywords

ERGOMETRINE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; RISK ASSESSMENT; VARIANT ANGINA PECTORIS;

COPPER; CORONARY VASOSPASM; ERGONOVINE; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0032890194     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00235-4     Document Type: Article

References (42)

1. Hills L.D., Braunwald E. Coronary-artery spasm. New Engl. J. Med. 299:1978;695-702.
2. Maseri A., Severi S., De Nes M., L'Abbate A., Chierchia S., Marzilli M. et al. Variant angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Am. J. Cardiol. 42:1978;1019-1035.
3. Roberts W.C., Curry R.C. Jr., Isner J.M., Waller B.F., McManus B.M., Mariani-Constantini R. et al. Sudden death in Prinzmetal's angina with coronary spasm documented by angiography. Am. J. Cardiol. 50:1982;203-210.
4. Kugiyama K., Kerns S.A., Morrisett J.D., Roverts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolesithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
5. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86:1990;75-79.
6. Tanner F.C., Noll D., Boulanger C.M., Lüscher T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Circulation. 83:1991;2012-2020.
7. Mangin Jr E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ. Res. 72:1993;161-166.
8. Galle J., Bassenge E., Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ. Res. 66:1990;1287-1293.
9. Miwa K., Miyagi Y., Fujita M. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J. Am. Coll. Cardiol. 26:1995;632-638.
10. Steinberg D. The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis. Eur. J. Clin. Invest. 8:1978;107-109.
11. Tall A.R. Plasma high density lipoproteins. J. Clin. Invest. 86:1991;379-384.
12. Johnson W.J., Mahlberg F.H., Rothblat G.H., Phillips M.C. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085:1991;273-298.
13. Kuhn F.E., Mohler E.R., Satler L.F., Reagan K., Lu D.Y., Rackley C.E. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am. J. Cardiol. 68:1991;1425-1430.
14. Nagano I., Hidenori A., Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA. 88:1991;6457-6461.
15. Salmon S., Mazière C., Auclair M., Theron L., Santus R., Mazière J. Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim. Biophys. Acta. 1125:1992;230-236.
16. Morel D.W. Reduced cholesterol efflux to mildly oxidized high density lipoprotein. Biochemi. Biophys. Res. Commn. 200:1994;408-416.
17. Bonnefont-Rousselot D., Motta C., Khalil A.O., Sola R., La Ville A.E., Delattre J. et al. Physiochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals: effect on their cholesterol effluxing capacity. Biochimi. Biophys. Acta. 1255:1995;23-30.
18. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89:1992;10-18.
19. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
21. Yagi K.A. simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
22. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free. Rad. Res. Comms. 6:1989;67-75.
23. Saku K., Ahmad M., Glas-Greenwalt P., Kashyap M.I. Activation of fibrinolysis by apoproteins of high density lipoproteins in man. Thromb. Res. 39:1985;1-8.
24. Fleisher L.N., Tall A.R., Witte L.D., Miller R.W., Cannon P.J. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J. Biol. Chem. 257:1982;6653-6655.
25. Yui Y., Aoyama T., Morishita H., Takotsu Y., Kawai C. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I): a novel function of Apo A-I. J. Clin. Invest. 82:1988;803-807.
26. Tauber J., Cheng J., Gospodarowicz D. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J. Clin. Invest. 66:1980;696-708.
27. Murugesan G., Sa G., Fox P.L. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ. Res. 74:1994;1149-1156.
28. Zeiher A.M., Schächinger V., Hohnloser S.H., Saurbier B., Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 89:1994;2525-2532.
29. Tasaki H., Nakashima Y., Nandate H., Yashiro A., Kawashima T., Kuroiwa A. Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects. Am. J. Cardiol. 63:1989;1441-1445.
30. Shirai K., Nii T., Imamura M., Kawano T., Mori T., Nakashima Y., Sasaki J., Arakawa K. Low serum apolipoprotein A-I level in patients with vasospastic angina. Am. Heart. J. 125:1993;320-323.
31. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044:1990;275-283.
32. Hahn M., Ravi Subbiah M.T. Significant association of lipid peroxidation products with high density lipoproteins. Biochem. Molecul. Biol. Int. 33:1994;699-704.
33. Maier J.A.M., Barenghi L., Bradamante S., Comi P., Ragnotti G. The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions. Eur. J. Biochem. 221:1994;35-41.
34. Mackness M.I., Abbott C., Arrol S., Durrington P.N. The role of high- density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294:1993;829-834.
35. Matsuda Y., Hirata K., Inoue N., Suematsu M., Kawasaki S., Akita H., Yokoyama M. High density lipoprotein reverses inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ. Res. 72:1993;1103-1109.
36. Liu R., Saku K., Zhang B., Hirata K., Shiomi M., Arakawa K. In vitro kinetics of oxidatively modified HDL. Biochemi. Med. Metabol. Biol. 49:1993;392-397.
37. La Ville A.E., Rosa S., Balanya J., Turner P.R., Masana L. In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implicaions for its protective role in vivo. Atherosclerosis. 105:1994;179-189.
38. Almor Y., Nègre-Sakvayre A., Levade T.H., Valdiguie P., Salvayré R. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL. Biochim. Biophys. Acta. 1128:1992;163-166.
39. Hurtado I., Fioln C., Gracia V., Clad P. In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis. 125:1996;39-46.
40. Simon B.C., Haudenschild C.C., Cohen R.A. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol. 21:1993;893-901.
41. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. New Engl. J. Med. 332:1995;488-493.
42. Miwa K., Miyagi Y., Igawa A., Nakagawa K., Inoue H. Vitamin E deficiency in variant angina. Circulation. 94:1996;14-18.